SC
CDMO

Scotia Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Scotia Capital’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,840
Closed -$13K – 872
2015
Q4 		$13K Hold
1,840
– – ﹤0.01% 793
2015
Q3 		$13K Hold
1,840
– – ﹤0.01% 767
2015
Q2 		$17K Hold
1,840
– – ﹤0.01% 738
2015
Q1 		$17K Hold
1,840
– – ﹤0.01% 598
2014
Q4 		$18K Hold
1,840
– – ﹤0.01% 565
2014
Q3 		$18K Buy
1,840
+200
+12% +$2.24K ﹤0.01% 578
2014
Q2 		$22K Buy
+1,640
New +$20.7K ﹤0.01% 563

Other funds holding CDMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Scotia Capital's CDMO Position: Q1 2016 in Review

Scotia Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2016, closing a stake of 1,840 shares — an estimated $13K sold.

Scotia Capital first reported a position in CDMO in Q2 2014 and held it in 7 quarters. The position peaked at $22K in Q2 2014. 84 funds tracked by Wall St. Rank hold CDMO as of Q1 2016.

  • Scotia Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Scotia Capital sold 1,840 Avid Bioservices, Inc. Common Stock shares in Q1 2016, an estimated $13K.
  • Scotia Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2014 and held it in 7 quarters.
  • Scotia Capital's Avid Bioservices, Inc. Common Stock position peaked at $22K in Q2 2014.
  • 84 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2016.

Based on Scotia Capital's 13F filing for Q1 2016, filed 12 May 2016.